Search

Search Constraints

You searched for: Subject Mutation (Biology) Remove constraint Subject: Mutation (Biology) Start Over

Search Results

7. Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation